Korean Biosimilar Firms Capitalize on Global Patent Expirations Samsung Bioepis, Celltrion Target Keytruda, Dupixent ...

As patents for "blockbuster" drugs—defined as those with annual sales exceeding $1 billion (approximately 1.4 trillion Korean ...

Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host diseaseRecommendation supported by safety and efficacy ...

Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...

By Bhanvi Satija LONDON, Feb 2 (Reuters) - French drugmaker Sanofi said on Monday that its experimental genetic disorder ...

In what is shaping up to be a back-loaded month, the FDA is set to release a slew of regulatory decisions in February, ...

Sanofi SNY announced that the European Commission has approved Teizeild (teplizumab) to delay the onset of stage 3 type 1 diabetes (T1D) in patients aged eight years and older with stage 2 disease.

President Donald Trump's approval ratings slightly dipped in most polls following a series of controversial events at the start of the president's second year of his second term in office. In the ...

The WNBA's 2026 regular season has a start date. What the WNBA still does not have is a new collective bargaining agreement that locks in historic contractual gains for players and reflects the league ...

She had some help from the creator of Barbicore. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Much has already been written about the fashion ...

Sen. Chris Murphy (D-Conn.) said Wednesday he believes in a “correlation between” President Trump’s falling approval rating and “his increasing authoritarian behavior.” “I do think there’s a ...